Skip to main content

Wyeth (NYSE: WYE) Shareholder Lawsuit Over Wyeth Acquisition By Pfizer As ‘Too Low’ Filed - 01/27/2009

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 2012 (Update) - Case dismissed. U.S. District Judge said Wyeth had sufficiently cautioned investors in a May 2007 press release. January 27, 2009 - A Wyeth shareholder filed a lawsuit over the proposed acquisition of Wyeth by Pfizer. The plaintiff asked a federal judge to block the drugmaker’s sale, saying that it’s “unlawful and unenforceable”, the $68 billion offer is too ...



You must register (for free) or login to view the entire case.